Articles that mention Novartis -BoardProspects

Novartis

0 Comments Leave a Comment

1-15 of 37 1 2 3 »
1. Mentioned In 37 Articles
2. Ric Kayne and Affiliates Confirm Nomination of Two Highly Qualified Candidates for Election to Athira Pharma’s Board of Directors
  
  Explore Yahoo! Finance Mar 31 2022 BoardNews
  
  ...confirmed that he has nominated himself and George W. Bickerstaff, III, the former Chief Financial Officer of Novartis Pharma AG, for election to Athiras Board of Directors... ...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Novartis Board
3. Ventus Therapeutics Appoints Three New Members to Board of Directors
  
  Explore biospace.com Dec 8 2021 BoardMoves
  
  ...served in multiple roles at the Novartis Institutes for Biomedical Research and the Genomics Institute of the Novartis Research Foundation, including as the Director of Kinase Biology, Head of Oncology Pharmacology. Whil...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi Twitter CFO
4. Roche Shareholders Approve Deal to Buy Novartis's $20.7 Billion Stake
  
  Explore Yahoo! Finance Nov 26 2021 BoardNews
  
  ... cancellation of the repurchased shares and of the interim financial statements prepared for the transaction. Novartis' involvement started in 2001, when Swiss activist investor Martin Ebner, known for orchestrating the ...
  Read Full Article
  
  Comment
  
  Mentions: Investment UBS stake
5. Adagio Therapeutics (ADGI) Announces Expansion of Management Team and Board of Directors
  
  Explore StreetInsider.com Nov 22 2021 BoardMoves
  
  ... Novartis, including senior leadership roles in legal and compliance at Novartis Pharmaceuticals Corporation, Novartis Consumer Health and Novartis Services. Ms. Andersen has worked extensively on matters related to prod...
  Read Full Article
  
  Comment
  
  Mentions: Management private equity firms acquisition
6. Former Novartis Executive Dr. Marie Lindner Joins Orthogon Therapeutics' Board of Directors
  
  Explore businesswire.com Nov 15 2021 BoardMoves
  
  ...ategic Pharma partnerships. She was previously the Global Program Head for the Strategic Partnerships team at Novartis. Additionally, Dr. Lindner was formerly a venture partner at BioAdvance investment fund (Radnor, PA) ...
  Read Full Article
  
  Comment
  
  Mentions: Shire Canada Australia
7. Novartis Cuts Uneasy 20-year Ties to Roche With $20.7 Billion Voting Stake Sale
  
  Explore Start Magazine Nov 4 2021 BoardNews
  
  ...s per share and for now put to rest lingering speculation that Roche could be eyeing larger acquisitions. For Novartis, the deal further simplifies its structure after the maker of drugs against diseases such as arthriti...
  Read Full Article
  
  Comment
  
  Mentions: Novartis Roche Holding Ltd veto power
8. The Curious Case Of Elliott Advisors And GSK: Are Activist Investors What They Used To Be?
  
  Explore forbes.com Jul 10 2021 BoardBlogs
  
  ...or the Consumer Healthcare business, becoming CEO of GSK Consumer Healthcare, a joint venture between GSK and Novartis, in March 2015. Prior to joining GSK she was with L’ Oreal for 17 hears where she had broad global ex...
  Read Full Article
  
  Comment
  
  Mentions: Investment IPO Harvard
9. Glaxo CEO Walmsley Buys Time as Strategy Gets Modest Backing
  
  Explore Yahoo! Finance Jun 23 2021 BoardNews
  
  ...ogy drugs on the market when Walmsley took the helm to having three. Her predecessor had sold the business to Novartis AG. Not everyone is convinced that Walmsley’s strategy for Glaxo breaks any new ground. Emily Field, ...
  Read Full Article
  
  Comment
  
  Mentions: Management Sanofi Barclays
10. Woke Capital Is Butting up Against Corporate Law Constraints | Opinion
  
  Explore Newsweek Jun 23 2021 BoardBlogs
  
  ...onditioning both compensation and future work on the answers matching up to Coke's rigid quotas. In February, Novartis AG (one of the world's largest pharmaceutical companies) followed suit. And companies as high-profile...
  Read Full Article
  
  Comment
  
  Mentions: Opinion Coca-Cola lawsuit
11. IMV Appoints Dr. Michael Kalos to Board of Directors
  
  Explore businesswire.com May 11 2021 BoardMoves
  
  ...the clinical cell therapy program at Penn, including development of the CTL019 program, which was licensed to Novartis and led to Kymriah, the first approved CART cell therapy product. Dr. Kalos obtained his Ph.D. from t...
  Read Full Article
  
  Comment
  
  Mentions: Nova IMV Eli Lilly
12. 20 Highest-Paid Biopharma CEOs
  
  Explore Pharma News Sep 18 2020 BoardNews
  
  ...($AZN) Pascal Soriot, for instance. GlaxoSmithKline's ($GSK) Andrew Witty. And this year, both Joe Jimenez of Novartis ($NVS) and Severin Schwan of Roche ($RHHBY) fell several million short of the cutoff. Then there's th...
  Read Full Article
  
  Comment
  
  Mentions: Twitter stock options Vertex
13. Gilead Reaches $21 Billion Deal for Immunomedics
  
  Explore MarketWatch Sep 13 2020 BoardNews
  
  ...e moved to establish beachheads in cancer treatment, creating a heavily contested battleground with stalwarts Novartis AG and Roche Holding AG. The desirability of cancer treatments, especially those like Trodelvy that h...
  Read Full Article
  
  Comment
  
  Mentions: acquisition stake Gilead Sciences
14. Royalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Company’s Board of Directors
  
  Explore GlobeNewswire Aug 4 2020 BoardMoves
  
  ...and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, and Vertex’s Kalydeco, Symdeko and Trikafta, and four development-stage product candidates...
  Read Full Article
  
  Comment
  
  Mentions: Board of Trustees Investor Relations Investment
15. Protara Therapeutics Announces Appointment of Barry P. Flannelly to Board of Directors
  
  Explore biospace.com Jul 24 2020 BoardMoves
  
  ... held roles of increasing responsibility in medical affairs, strategic planning, and commercial operations at Novartis Pharmaceuticals Corporation, Abraxis Oncology, Onyx Pharmaceuticals, Inc., and Nektar Therapeutics. T...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi Nasdaq University of Maryland
16. Coronavirus Treatments - If More Women Are On The Board, It’s Likely Safer, New Study Finds
  
  Explore forbes.com May 9 2020 BoardBlogs
  
  ... issued a warning about in an editorial. The company developing this highly controversial COVID-19 treatment, Novartis, has four women on their board of 14 members. It includes at least two formidable women who one would...
  Read Full Article
  
  Comment
  
  Mentions: Women Female culture
17. 1-15 of 37 1 2 3 »